Publication date: 19 September 2017
Source:Cell Reports, Volume 20, Issue 12
Author(s): Simon Koplev, James Longden, Jesper Ferkinghoff-Borg, Mathias Blicher Bjerregård, Thomas R. Cox, Janine T. Erler, Jesper T. Pedersen, Franziska Voellmy, Morten O.A. Sommer, Rune Linding
Signaling networks are nonlinear and complex, involving a large ensemble of dynamic interaction states that fluctuate in space and time. However, therapeutic strategies, such as combination chemotherapy, rarely consider the timing of drug perturbations. If we are to advance drug discovery for complex diseases, it will be essential to develop methods capable of identifying dynamic cellular responses to clinically relevant perturbations. Here, we present a Bayesian dose-response framework and the screening of an oncological drug matrix, comprising 10,000 drug combinations in melanoma and pancreatic cancer cell lines, from which we predict sequentially effective drug combinations. Approximately 23% of the tested combinations showed high-confidence sequential effects (either synergistic or antagonistic), demonstrating that cellular perturbations of many drug combinations have temporal aspects, which are currently both underutilized and poorly understood.
Graphical abstract
Teaser
Therapeutic strategies, such as combination chemotherapy, rarely consider the timing of drug perturbations. Koplev et al. present a Bayesian dose-response framework for the prediction of sequentially effective drug combinations. They find widespread time dependency that is partially conserved between cancer cells of the same tissue origin.http://ift.tt/2xvUvlc
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου